GlobeNewswire Inc | Oct 19, 2021 08:30AM EDT

October 19, 2021

SAN CLEMENTE, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health-solutions company, announced Thomas Stankovich, Chief Financial Officer of the Company, will present at the Annual Small Cap Growth Conference hosted by Dawson James Securities on October 21, 2021, at the Wyndham Grand Hotel in Jupiter, Florida.

During Mr. Stankovichs presentation, he will provide an overview of the Companys business operations and highlight ongoing value creation efforts across ReShapes commercial portfolio of weight-loss products and services.

Details of the presentation are below:

Event: 6th Annual Dawson James Small Cap Growth ConferenceDate: Thursday, October 21, 2021 Time: 2:25 p.m. ET Location: Track 1 Preserve C

Investors participating in the conference who would like to schedule a one-on-one meeting with ReShapes management may do so by contacting their Dawson James representative or Daniel Kontoh-Boateng of The Ruth Group at dboateng@theruthgroup.com.

An audio webcast of ReShapes presentation will be available on the investor relations section of the Companys website,ir.reshapelifesciences.com. Replays of the webcast will be available for 90 days after the date of the presentation.

ABOUTRESHAPE LIFESCIENCES INC.ReShape Lifesciences is America's premier weight loss and metabolic health-solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease. The FDA-approved Lap-Band Program provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures such as the gastric bypass or sleeve gastrectomy. The ReShape Vest System is an investigational (outside theU.S.) minimally invasive, laparoscopically implanted medical device that wraps around the stomach, emulating the gastric volume reduction effect of conventional weight-loss surgery. It helps enable rapid weight loss in obese and morbidly obese patients without permanently changing patient anatomy. reshapecare is a virtual weight-management program that supports lifestyle changes for all weight-loss patients led by board certified health coaches to help them keep the weight off over time. The recently launched ReShape Marketplace is an online collection of quality wellness products curated for all consumers to help them achieve their health goals.

CONTACTSReShape Lifesciences Investor Contact:Thomas StankovichChief Financial Officer949-276-6042ir@ReShapeLifesci.com

Investor Contact:Daniel Kontoh-BoatengAssistant Vice PresidentThe Ruth Group646-536-7019dboateng@theruthgroup.com